Biohaven

Biohaven is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative treatments for neurological diseases, as well as other therapeutic areas such as immunology, obesity, and oncology. The company is known for its successful migraine treatments, including Nurtec ODT and Zavzpret, and is... advancing a diverse portfolio of drug development programs aimed at addressing significant unmet medical needs. Biohaven operates with a patient-first culture, emphasizing urgency and scientific innovation to bring life-changing therapies to market. Their commitment to collaboration and cutting-edge research positions them as a leader in transforming the treatment landscape for challenging diseases.Read More